Kiromic BioPharma, Inc. (KRBP)

OTCMKTS: KRBP · Delayed Price · USD

3.200

-0.020 (-0.62%)

May 31, 2024, 3:36 PM EDT - Market closed

Kiromic BioPharma Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018
Selling, General & Admin	10.31	17.19	13.94	14.14	2.5	Upgrade
Research & Development	9.62	13.92	11.37	5.05	1.2	Upgrade
Other Operating Expenses	0	0	0.05	0	0	Upgrade
Operating Expenses	19.94	31.11	25.31	19.2	3.71	Upgrade
Operating Income	-19.94	-31.11	-25.74	-19.2	-3.71	Upgrade
Interest Expense	-1.85	0.17	0.01	0	0.02	Upgrade
Other Expense / Income	2.86	3.45	-0.16	-	-	Upgrade
Pretax Income	-20.95	-34.73	-25.59	-19.2	-3.73	Upgrade
Income Tax	0	3.45	0.07	0	0.02	Upgrade
Net Income	-20.95	-38.18	-25.65	-19.2	-3.75	Upgrade
Shares Outstanding (Basic)	1	1	0	0	0	Upgrade
Shares Outstanding (Diluted)	1	1	0	0	0	Upgrade
Shares Change	101.57%	43.07%	153.41%	16.14%	9.82%	Upgrade
EPS (Basic)	-19.09	-70.12	-67.40	-127.86	-29.00	Upgrade
EPS (Diluted)	-19.09	-70.12	-67.40	-127.86	-29.00	Upgrade
Free Cash Flow	-21.43	-28.63	-22.22	-7.58	-3.22	Upgrade
Free Cash Flow Per Share	-19.53	-52.57	-58.37	-50.50	-24.87	Upgrade
EBITDA	-19.94	-29.44	-24.78	-19	-3.62	Upgrade
Depreciation & Amortization	2.22	1.67	0.47	0.2	0.09	Upgrade
EBIT	-22.16	-31.11	-25.25	-19.2	-3.71	Upgrade

Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.